MedTrace Logo

Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease

NCT02278107 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-02-29

No results posted yet for this study

Summary

A preliminary study to evaluate a new nasal interface and portable ventilator system in comparison to standard oxygen therapy in patients with severe chronic lung disease.

Conditions

Interventions

DEVICE

Tidal Assist Ventilator System

Tidal volume augmentation with supplemental oxygen. Source gas options: cylinder, concentrator, wall.

DEVICE

Nasal Cannula Oxygen

Standard oxygen therapy delivered by nasal cannula at 2-5 lpm based on patient requirements. Source gas options: cylinder, concentrator, wall.

Sponsors & Collaborators

  • New Aera, Inc

    lead INDUSTRY

Principal Investigators

  • Richard Kops, MD · John Muir Medical Center, Concord Campus

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278107 on ClinicalTrials.gov